ロード中...
Polyuria due to vasopressin V2 receptor antagonism is not associated with increased ureter diameter in ADPKD patients
BACKGROUND: Tolvaptan, a vasopressin V2 receptor antagonist, has been shown to reduce the rates of growth in total kidney volume (TKV) and renal function loss in ADPKD patients, but also leads to polyuria because of its aquaretic effect. Prolonged polyuria can result in ureter dilatation with conseq...
保存先:
| 出版年: | Clin Exp Nephrol |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5497698/ https://ncbi.nlm.nih.gov/pubmed/27339446 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10157-016-1297-1 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|